Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7021163b729521289028313faa08a079 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5256 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-15022 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-24043 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-525 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
filingDate |
2002-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9aeca08602e0c6300c02e48112157f8 |
publicationDate |
2002-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2448620-A1 |
titleOfInvention |
Vaccination against the feline immunodeficiency virus |
abstract |
The invention relates to a kit for vaccinating cats against FIV, comprising a first vaccine comprising a plasmid containing and expressing in vivo a polynucleotide coding for env and/or gag and/or gag/pro of FIV in a vehicle or excipient which is pharmaceutically acceptable and a second vaccine comprising a viral.vector containing and expressing in vivo a polynucleotide coding for env and/or gag and/or gag/pro of FIV in a vehicle or excipient which is pharmaceutically acceptable, said vaccines being packed separately, with the proviso that at least one of the proteins env or gag or gag/pro is coded by the plasmids and the viral vectors. The plasmids and/or viral vectors are used in the preparation of vaccines against FIV. |
priorityDate |
2001-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |